Fragment-Based Drug Discovery

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 36: Line 36:
| align="center" | <scene name='Sandbox_reserved_394/Phe109_and_ala108/1'>Ala108</scene> || align="center" | <scene name='Sandbox_reserved_394/Tyrosine_105/1'>Tyr105</scene> || align="center" | <scene name='Sandbox_reserved_394/Phe_101/1'>Phe101</scene> || align="center" | <scene name='Sandbox_reserved_394/Glycine_142/1'>Gly142</scene>
| align="center" | <scene name='Sandbox_reserved_394/Phe109_and_ala108/1'>Ala108</scene> || align="center" | <scene name='Sandbox_reserved_394/Tyrosine_105/1'>Tyr105</scene> || align="center" | <scene name='Sandbox_reserved_394/Phe_101/1'>Phe101</scene> || align="center" | <scene name='Sandbox_reserved_394/Glycine_142/1'>Gly142</scene>
|}
|}
-
The ligand is a member of the <scene name='Sandbox_reserved_394/Abt-737/1'>ABT-737</scene> family. ABT-737 has been shown to effectively inhibit the over-expression of this protein thereby inducing tumor regression and increasing chemo-sensitivity.
+
 
 +
 
 +
=== ABT-737 ===
 +
----
 +
 
 +
Using this acylsulfonamide-based ligand as a template, or pharmacophore, other drugs can be designed to have similar effects. <scene name='Sandbox_reserved_394/Abt-737/1'>ABT-737</scene> has been shown to effectively inhibit the over-expression of this protein thereby inducing tumor regression and increasing chemo-sensitivity.

Revision as of 18:24, 3 October 2012

Apoptosis by Inhibition of Bcl-2 Family Proteins

Structure of Bcl-xl/Acyl-sulfonamide complex (PDB entry 1ysi)

Drag the structure with the mouse to rotate

References

  1. Oltersdorf T., Elmore S.W., Shoemaker A.R. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Vol 435|2 June 2005|doi:10.1038/nature03579

Proteopedia Page Contributors and Editors (what is this?)

Justin Weekley, Arthur Cox, Jaime Prilusky

Personal tools